Shandong Sanyuan Biotechnology Co (301206) Fair Value & Analysis
Consumer Defensive · CN · Market cap 4.8B CNY
Analysis
Shandong Sanyuan Biotechnology Co (301206) currently trades at ¥24.00, while our model-based Fair Value estimate is ¥14.34 — implying the stock looks roughly 40.3% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, the United States, East Asia, Southeast Asia, Australia, New Zealand, and Africa. Shandong Sanyuan Biotechnology Co.,Ltd. was founded in 2007 and is based in Binzhou, China.
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.